Skip to main content
Adam Schoenfeld, MD, Oncology, New York, NY

Adam Jacob Schoenfeld MD

Thoracic Cancer


Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Request Appointment
  • 530 East 74th StreetNew York, NY 10021

  • Book by Phone+1(814) 257-5653

Overview of  Dr. Schoenfeld

Dr. Adam Schoenfeld is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 12 years. He is one of 527 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 90 publications and over 500 citings.

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterResidency, Gastroenterology, 2020 - 2026
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2014 - 2017
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2014, AOA

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - Present
  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2020 - 2027
  • NY State Medical License
    NY State Medical License 2017 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Kaiser Permanente Medical Student Scholarship Award Kaiser Permanente, 2013
  • New England Journal of Medicine Scholar New England Journal of Medicine, 2012
  • Phi Beta Kappa Society Member Dartmouth College, 2009

Publications & Presentations

PubMed

Journal Articles

  • Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung Cancers  
    Helena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
  • Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane Complexes  
    Chapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
  • Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...  
    Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010

Abstracts/Posters

  • The CNS Germinoma Experience at UCSF from 1980 to 2010
    Schoenfeld A, Molinaro A, Banerjee A, Haas-Kogan D, Mueller S, 3rd International CNS Germ Cell Tumour Symposium, Cambridge, England, 2013

Lectures

  • Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer
    Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung CancerNovember 7th, 2025
  • Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual Meeting
    Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual MeetingOctober 30th, 2025
  • Study Finds Growing Reason to Be Wary of Some Reflux Drugs
    Study Finds Growing Reason to Be Wary of Some Reflux DrugsJanuary 29th, 2016

Grant Support

  • DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung CancerSLOAN-KETTERING INST CAN RESEARCH2025–2030

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: